TScan Therapeutics, Inc. - 8-K Filing

TScan Therapeutics approved a retention program for key employees including CEO and CLO with cash awards and RSUs tied to milestones. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)

SEC EDGAR ·

Tickers: $TCRX

Read the full article at SEC EDGAR

More Regulatory news